Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMAL-BP: Intensive vs Standard BP Control after Thrombectomy
NCT04205305Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jun 2020
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of labetalol, nicardipine in ischemic stroke, sponsored by Yonsei University. Started Jun 2020; status: completed.
02
Drugs
labetalolnicardipine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04205305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04205305.